ProPhase Labs, Inc. Due to Affiliate, Current
ProPhase Labs, Inc. (PRPH) had Due to Affiliate, Current of $59.00 thousand as of 2017-12-31, per its 10-K filed 2019-03-26.
Discontinued › Notes
us-gaap:DueToAffiliateCurrent · last filed 2019-03-26
- 2017-12-31: Due to Affiliate, Current $59.00K.
| Period end | Due to Affiliate, Current |
|---|---|
| 2017-12-31 | $59.00K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |